Favorable Long-Term Outcome of Maze Surgery in Patients With Lone Atrial Fibrillation Martin E.W. Hemels, MD, Youlan L. Gu, MS, Anton E. Tuinenburg, MD, PhD, Piet W. Boonstra, MD, PhD, Ans C.P. Wiesfeld, MD, PhD, Maarten P. van den Berg, MD, PhD, Dirk J. Van Veldhuisen, MD, PhD, Isabelle C. Van Gelder, MD, PhD The Annals of Thoracic Surgery Volume 81, Issue 5, Pages 1773-1779 (May 2006) DOI: 10.1016/j.athoracsur.2005.10.007 Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Survival free of atrial fibrillation (AF) after Cox maze III surgery. (AAD = antiarrhythmic drugs.) The Annals of Thoracic Surgery 2006 81, 1773-1779DOI: (10.1016/j.athoracsur.2005.10.007) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Comparison of the Short-Form Health Survey (SF-36) quality of life scores between patients who underwent Cox maze III surgery (black bars; n = 27) and a control group of 120 healthy subjects (gray bars) in our database (with age- and sex-matched distribution). Data are shown as scores (maximum value = 100) on the eight scales of the SF-36. No statistical difference could be demonstrated on any scale. The Annals of Thoracic Surgery 2006 81, 1773-1779DOI: (10.1016/j.athoracsur.2005.10.007) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions